BRISTOL-MYERS SQUIBB COMPANY Restructuring Reserve, Translation and Other Adjustment
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Restructuring Reserve, Translation and Other Adjustment of $0 as of 2019-01-01, per its 10-K filed 2021-02-10.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveTranslationAndOtherAdjustment · last filed 2021-02-10
- 2019-01-01: Restructuring Reserve, Translation and Other Adjustment $0.00; Restructuring Reserve, Translation and Other Adjustment as first filed -$3.00M.
- 2018-01-01: Restructuring Reserve, Translation and Other Adjustment -$3.00M; Restructuring Reserve, Translation and Other Adjustment as first filed $0.00.
- 2017-01-01: Restructuring Reserve, Translation and Other Adjustment $0.00.
| Period end | Restructuring Reserve, Translation and Other Adjustment | Restructuring Reserve, Translation and Other Adjustment as first filed |
|---|---|---|
| 2019-01-01 | $0.00 10-K · filed 2021-02-10 | -$3.00M 10-Q · filed 2019-04-25 |
| 2018-01-01 | -$3.00M 10-K · filed 2021-02-10 | $0.00 10-Q · filed 2019-04-25 |
| 2017-01-01 | $0.00 10-K · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |